Skip to main content
HiRO Regulatory Affairs
HiRO Regulatory Affairs
* Strategic * Informed * Proactive * Global
* Strategic * Informed * Proactive * Global
* Strategic * Informed * Proactive * Global
* Strategic * Informed * Proactive * Global
* Strategic * Informed * Proactive * Global
* Strategic * Informed * Proactive * Global
* Strategic * Informed * Proactive * Global
* Strategic * Informed * Proactive * Global
IRO For Regulatory Affairs

01

Global Development Strategy & Early Planning

Program-level regulatory roadmaps that align development plans with U.S., European, and APAC approval pathways.

02

CMC & Non-Clinical Consulting

Guidance to align CMC and non-clinical packages with global expectations and reduce downstream review risk.

03

INDs / CTA & Lifecycle Management

End-to-end support for Pre-INDs, CTAs, and ongoing maintenance—ensuring compliance and continuity across phases.

04

Expedited Pathways & Special Designations

Guidance and support for special designations and expedited pathways for FDA, NMPA, EMA, and other global authorities.

05

Marketing Authorization & Submissions

NDA, BLA, and MAA preparation, review, and submission support across major global health authorities.